Skip to content
  • About
    • Our Science
    • Publications
    • Board of Directors
    • Partners
    • Scientific Advisory Board
  • Cancer Testing
    • Aristotle Test
    • AVRT Cancer Prevention
    • Employer Program
    • FireFighters
  • Investors
    • Corporate Governance
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In The News
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
  • About
    • Our Science
    • Publications
    • Board of Directors
    • Partners
    • Scientific Advisory Board
  • Cancer Testing
    • Aristotle Test
    • AVRT Cancer Prevention
    • Employer Program
    • FireFighters
  • Investors
    • Corporate Governance
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In The News
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers

Investor FAQ

SEDAR Information

  1. SEDAR+ Company Profile.
  2. Interim financial statements/report – Sept 30, 2024
  3. Interim MD&A – Sept 30, 2024
  4. Interim financial statements/report – June 30, 2024
  5. Interim MD&A – June 30, 2024
  6. Interim financial statements/report – March 31, 2024
  7. Interim MD&A – March 31, 2024

StageZero Life Sciences. Ltd.
​30-70 East Beaver Creek Road
Richmond Hill, Ontario L4B 3B2

StageZero Life Sciences, Inc.
​3705 Saunders Avenue
Richmond, VA 23227
​TEL: 855.420.7140 

  • Notice of Privacy Practices
  • Terms & Conditions
  • Privacy Statement & Policy
  • Licensing & Accreditation

Copyright @2025 StageZero Life Sciences. All rights reserved.